BioNTech (NASDAQ:BNTX) said it has agreed to buy bispecific antibody developer Biotheus for up to $950M, including $150M in potential milestone payments. Under the deal, BioNTech (BNTX) will pay $800M ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

You probably have a cabinet full of rapid COVID-19 tests you’ve accumulated. The expiration dates have come closer and closer, with some tests even reaching them. The Food and Drug Administration, ...

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...

BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, November 4, 2024, at 8:00 a.m. EST (2:00 p.m. CET) to report its financial ...

These antigen tests, often called rapid tests, detect proteins called antigens from the virus that causes Covid-19. They can provide positive or negative test results within minutes in your own home.

England have announced their 16-member squad for the tour of New Zealand, that includes three Tests, starting 28 November. All-rounder Jacob Bethell has earned a maiden call-up to the senior side. The ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price target of $145.00. The company’s shares closed last ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and ... companies to first test the vaccines in people.

With access to COVID-19 rapid tests becoming increasingly difficult in Windsor, a former director of Ontario's COVID-19 Science Advisory Table is advising people to do all they can to avoid ...